Statins after cardiac transplantation: Which statin, what dose, and how low should we go?

被引：15

作者：

Ballantyne, CM ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

来源：

JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2000年 / 19卷 / 06期

关键词：

D O I：

10.1016/S1053-2498(00)00125-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：515 / 517

页数：3

共 26 条

[1] Cyclosporine plasma unbound fraction in heart and lung transplantation recipients
Akhlaghi, F
Ashley, J
Keogh, A
Brown, K
[J]. THERAPEUTIC DRUG MONITORING, 1999, 21 (01) : 8 - 16
[2] HYPERLIPIDEMIA AFTER HEART-TRANSPLANTATION - REPORT OF A 6-YEAR EXPERIENCE, WITH TREATMENT RECOMMENDATIONS
BALLANTYNE, CM
RADOVANCEVIC, B
FARMER, JA
FRAZIER, OH
CHANDLER, L
PAYTONROSS, C
COCANOUGHER, B
JONES, PH
YOUNG, JB
GOTTO, AM
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (06) : 1315 - 1321
[3] BALLANTYNE CM, 1987, TRANSPL P, V19, P60
[4] Lipid treatment and survival after heart transplantation
Ballantyne, CM
Short, BC
Bourge, RC
Eisen, HJ
Fishbein, DP
Kubo, SH
Lake, KD
Badovancevic, B
Taylor, DO
Ventura, HO
Yancy, CW
Young, JB
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 157A - 158A
[5] Treatment of hyperlipidemia after heart transplantation and rationale for the heart transplant lipid registry
Ballantyne, CM
Bourge, RC
Domalik, LJ
Eisen, HJ
Fishbein, DP
Kubo, SH
Lake, KD
Radovancevic, B
Taylor, DO
Ventura, HO
Yancy, CW
Young, JB
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (05) : 532 - 535
[6] Campeau L, 1997, NEW ENGL J MED, V336, P153
[7] Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: Are the statins mechanistically similar?
Christians, U
Jacobsen, W
Floren, LC
[J]. PHARMACOLOGY & THERAPEUTICS, 1998, 80 (01) : 1 - 34
[8] RHABDOMYOLYSIS AND RENAL INJURY WITH LOVASTATIN USE - REPORT OF 2 CASES IN CARDIAC TRANSPLANT RECIPIENTS
CORPIER, CL
JONES, PH
SUKI, WN
LEDERER, ED
QUINONES, MA
SCHMIDT, SW
YOUNG, JB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (02): : 239 - 241
[9] REVERSAL OF LOVASTATIN-MEDIATED INHIBITION OF NATURAL-KILLER-CELL CYTOTOXICITY BY INTERLEUKIN-2
CUTTS, JL
BANKHURST, AD
[J]. JOURNAL OF CELLULAR PHYSIOLOGY, 1990, 145 (02) : 244 - 252
[10] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
Downs, JR
Clearfield, M
Weis, S
Whitney, E
Shapiro, DR
Beere, PA
Langendorfer, A
Stein, EA
Kruyer, W
Gotto, AM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622

← 1 2 3 →